Uncategorized

The FDA Wants to Watch Your Clinical Trial in Real Time • Novartis Feels the Patent Cliff • Lilly Inks Its Sixth Deal

The FDA’s real-time clinical trial announcement is the most structurally significant regulatory initiative since the Expedited IND proposal in March. For 60 years, clinical trial

Uncategorized

Rhythm Imcivree HO Approval | Lilly Retatrutide Phase 3 Triple Agonist | GLP-1 Metabolic Monopoly

Thursday delivered two of the quarter’s most consequential catalysts, and both landed exactly where the data said they would. Rhythm Pharmaceuticals secured FDA approval for

Biotech

Cytek Biosciences to Present at Multiple Investor Conferences

Flow cytometry leader schedules presentations at three major healthcare investment conferences Cytek Biosciences announced its participation in three prominent investor conferences: the UBS Precision Medicine

Uncategorized

The FDA Wants to Watch Your Clinical Trial in Real Time • Novartis Feels the Patent Cliff • Lilly Inks Its Sixth Deal

Rhythm Imcivree HO Approval | Lilly Retatrutide Phase 3 Triple Agonist | GLP-1 Metabolic Monopoly

Cytek Biosciences to Present at Multiple Investor Conferences

Join 85,000+ Biotech, MedTech, and Pharma Leaders

Your Daily Edge in Biotech, MedTech, and Pharma

Get trusted, high-signal updates every morningBreakthroughs, trial data, deals, and the news that matters

Get trusted, high-signal updates every morning
Breakthroughs, trial data, deals, and the news that matters